ANTEPAR
LOE ApproachingNDAORALTABLETPriority Review
Approved
Jan 1957
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
4
Data completeness
2/8 — Basic
Priority Review
Drug data last refreshed 20h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
ANTEPAR is an oral small-molecule tablet approved by GSK in 1957 as a legacy NDA product. The specific therapeutic indication and mechanism of action are not documented in current data sources, suggesting this is a historic or discontinued product. Patient use patterns and clinical relevance require archival research.
LOE Approaching
Product is in late-stage lifecycle with minimal commercial activity; career opportunities likely limited to regulatory compliance, supply chain, or legacy portfolio management.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (4)
Treatment for Antepartum Posttraumatic Stress Disorder/PTSD Study
Started Mar 2023
240 enrolled
PTSD
Comparison of Oral Ferrous Sulfate to Intravenous Ferumoxytol in Antepartum Iron Deficiency Anemia
Started Jan 2021
83 enrolled
Pregnancy RelatedAnemia, Iron Deficiency
Heparin Prophylaxis Dosing for Antepartum Hospitalizations (HEPDOSE)
Started Dec 2020
46 enrolled
Pregnancy RelatedAntepartum DVT
Antepartum Etonogestrel Contraceptive Implant Insertion at Term
Started Jan 2019
0Contraception
Career Relevance
Worked on ANTEPAR at GSK? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.